Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.3760
-0.0340 (-8.29%)
At close: Apr 1, 2025, 4:00 PM
0.3879
+0.0119 (3.18%)
After-hours: Apr 1, 2025, 4:25 PM EDT

Turnstone Biologics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
-17.834.73123.38
Short-Term Investments
-76.9847.3337.64
Cash & Short-Term Investments
45.2894.7882.06161.02
Cash Growth
-52.22%15.50%-49.04%-
Receivables
-0.198.736.72
Prepaid Expenses
-4.665.089.23
Restricted Cash
-0.120.380.38
Other Current Assets
-2.811.75-
Total Current Assets
-102.5598177.34
Property, Plant & Equipment
-9.1214.369.37
Other Long-Term Assets
-1.142.580.54
Total Assets
-112.82114.94187.24
Accounts Payable
-0.043.440.03
Accrued Expenses
-9.9110.2214.03
Current Portion of Leases
-2.031.960.66
Current Income Taxes Payable
---0.25
Current Unearned Revenue
--15.1433.03
Other Current Liabilities
--4.066.97
Total Current Liabilities
-11.9734.8354.98
Long-Term Leases
-1.193.212.02
Long-Term Unearned Revenue
--4.1639.37
Other Long-Term Liabilities
-0.992.270.97
Total Liabilities
-14.1544.4697.34
Common Stock
-0.0200.02
Additional Paid-In Capital
-275.5220.59.1
Retained Earnings
--176.76-121.56-90.72
Comprehensive Income & Other
--0.12-0.41-0.25
Total Common Equity
43.6498.67-101.47-81.85
Shareholders' Equity
43.6498.6770.4889.9
Total Liabilities & Equity
-112.82114.94187.24
Total Debt
1.73.215.172.68
Net Cash (Debt)
43.5991.5676.9158.34
Net Cash Growth
-52.40%19.07%-51.44%-
Net Cash Per Share
1.897.9230.9558.65
Filing Date Shares Outstanding
23.1323.13.032.15
Total Common Shares Outstanding
23.1323.12.922.15
Working Capital
-90.5863.17122.37
Book Value Per Share
1.894.27-34.80-38.08
Tangible Book Value
43.6498.67-101.47-81.85
Tangible Book Value Per Share
1.894.27-34.80-38.08
Machinery
-11.7314.045.93
Construction In Progress
---2.94
Leasehold Improvements
-1.311.311.31
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q